NEOPLASMS BY SITE
Clinical trials for NEOPLASMS BY SITE explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS BY SITE trials appear
Sign up with your email to follow new studies for NEOPLASMS BY SITE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise in Hard-to-Treat cancers
Disease control CompletedThis study tested an experimental drug (BMS-986016) that targets LAG-3, given alone or with another immunotherapy (nivolumab), in people with advanced solid tumors that had spread or couldn't be removed by surgery. The goal was to see if the combination was safe and could shrink …
Matched conditions: NEOPLASMS BY SITE
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 26, 2026 08:49 UTC
-
New shot version of cancer drug shows promise in early study
Disease control CompletedThis study tested a new way to give the cancer drug nivolumab: as a shot under the skin instead of through an IV. It included 139 people with advanced cancers like lung, kidney, melanoma, liver, and colorectal cancer. The main goal was to see how the drug behaves in the body and …
Matched conditions: NEOPLASMS BY SITE
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Experimental CAR-T therapy targets tough blood cancers in small early trial
Disease control CompletedThis early-phase study tested a new treatment called RD13-02, which uses a patient's own immune cells modified to attack cancer cells with a specific marker (CD7). It involved just 2 people with blood cancers like T-cell acute lymphoblastic leukemia that had come back or not resp…
Matched conditions: NEOPLASMS BY SITE
Phase: EARLY_PHASE1 • Sponsor: MEI HENG • Aim: Disease control
Last updated May 04, 2026 16:24 UTC
-
New imaging catches cancers standard MRI misses in prostate patients
Diagnosis CompletedThis study tested whether two advanced imaging techniques—high-resolution MRI and a special PET-MRI scan—can find prostate cancers that standard MRI might miss. 62 men who were considering focal HIFU therapy or prostate removal took part. The goal was to see if these newer scans …
Matched conditions: NEOPLASMS BY SITE
Phase: PHASE2 • Sponsor: Alessandro D'Agnolo • Aim: Diagnosis
Last updated May 26, 2026 08:31 UTC